SALIX PHARMACEUTICALS LTD Finite-Lived Intangible Asset, Expected Amortization, Year Three
SALIX PHARMACEUTICALS LTD had Finite-Lived Intangible Asset, Expected Amortization, Year Three of $45.40 million as of 2012-12-31, per its 10-K filed 2013-03-01.
Discontinued › Notes › Intangible Assets › Goodwill and Other › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree · last filed 2013-03-01
- 2012-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Three $45.40M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year Three |
|---|---|
| 2012-12-31 | $45.40M 10-K · filed 2013-03-01 |